Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research article

Decline in reported AIDS cases in Brazil after implementation of the test and treat initiative

Authors: Gerson Fernando Mendes Pereira, Meritxell Sabidó, Alessandro Caruso, Adele Schwartz Benzaken

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

To evaluate the trends in AIDS detection and the AIDS-attributed death rate in Brazil between 2007 and 2015 and to determine the population characteristics associated with AIDS detection.

Methods

Surveillance data including demographics, mode of HIV transmission, AIDS cases, and AIDS-attributed deaths were analysed. A logistic regression model was fitted to assess the trends in AIDS cases by mode of HIV transmission throughout the study period. A segmented Poisson regression model was used to assess changes in the trends of AIDS detection and mortality rates before (2007–2014) and after (2015) the introduction of the Test and Treat Initiative.

Results

In the segmented Poisson regression, the decline in the AIDS detection rate from 2007 to 2014 was 2.0% annually (i.e., the odds ratio (OR) for annual decline was 0.98 (95% [CI: 0.98–1.00, p-value < 0.001). The observed AIDS detection rate in 2015 was 7.7 cases per 100,000, which was 60% lower than the regression estimate of 19.8 for the hypothetical absence of the Test and Treat Initiative. The reduction in AIDS-attributed deaths from 2007 to 2014 was 8.0% annually (i.e., the OR for annual decline was 0.92 (95% [CI: 0.91–0.95, p-value < 0.001). The observed AIDS mortality rate in 2015 was 0.49 cases per 100,000, which was 73% lower than the regression estimate of 2.1 for the hypothetical absence of the Test and Treat Initiative in 2015.

Conclusions

Our results reveal a fairly stable AIDS detection rate from 2007 to 2014, with a sudden significant drop in 2015. This drop may be related to the increasing trends in rapid testing, the number of new HIV diagnoses, the number of patients on antiretroviral therapy (ART), and a median CD4 count at ART enrolment. Further evaluation of the effects of the Test and Treat Initiative on AIDS diagnosis and mortality is needed and must be strengthened with additional data from subsequent years.
Literature
3.
go back to reference Kerr L, Kendall C, Guimaraes MDC, Salani Mota R, Veras MA, Dourado I, Maria de Brito A, Merchan-Hamann E, Pontes AK, Leal AF, et al. HIV prevalence among men who have sex with men in Brazil: results of the 2nd national survey using respondent-driven sampling. Medicine (Baltimore). 2018;97(1S Suppl 1):S9–S15.CrossRef Kerr L, Kendall C, Guimaraes MDC, Salani Mota R, Veras MA, Dourado I, Maria de Brito A, Merchan-Hamann E, Pontes AK, Leal AF, et al. HIV prevalence among men who have sex with men in Brazil: results of the 2nd national survey using respondent-driven sampling. Medicine (Baltimore). 2018;97(1S Suppl 1):S9–S15.CrossRef
4.
go back to reference Bastos FI. Rates of HIV infection and syphilis and inventory of knowledge, attitudes and risk practices related to sexually transmitted infections among drug users in 10 brazilian municipalities. In: Technical report presented to the department of STD, AIDS and viral hepatitis; 2009. Bastos FI. Rates of HIV infection and syphilis and inventory of knowledge, attitudes and risk practices related to sexually transmitted infections among drug users in 10 brazilian municipalities. In: Technical report presented to the department of STD, AIDS and viral hepatitis; 2009.
5.
go back to reference Ferreira-Junior ODC, Guimaraes MDC, Damacena GN, de Almeida WDS, de Souza-Junior PRB, Szwarcwald CL, Brazilian FSWG. Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016. Medicine (Baltimore). 2018;97(1S Suppl 1):S3–8.CrossRef Ferreira-Junior ODC, Guimaraes MDC, Damacena GN, de Almeida WDS, de Souza-Junior PRB, Szwarcwald CL, Brazilian FSWG. Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016. Medicine (Baltimore). 2018;97(1S Suppl 1):S3–8.CrossRef
8.
go back to reference Brazilian Ministry of Health: [Recommendations for antiretroviral treatment for adults and adolescents with HIV-2001]. Brasília, DF: Brazilian Ministry of Health; 2001. Brazilian Ministry of Health: [Recommendations for antiretroviral treatment for adults and adolescents with HIV-2001]. Brasília, DF: Brazilian Ministry of Health; 2001.
12.
go back to reference Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017:48–355. Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017:48–355.
13.
go back to reference Group TAS, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, et al. A trial of early Antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808–22.CrossRef Group TAS, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, et al. A trial of early Antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808–22.CrossRef
14.
go back to reference Group ISS, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRef Group ISS, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRef
15.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef
17.
go back to reference Montaner JS, Lima VD, Harrigan PR, Lourenco L, Yip B, Nosyk B, Wood E, Kerr T, Shannon K, Moore D, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. PLoS One. 2014;9(2):e87872.CrossRef Montaner JS, Lima VD, Harrigan PR, Lourenco L, Yip B, Nosyk B, Wood E, Kerr T, Shannon K, Moore D, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. PLoS One. 2014;9(2):e87872.CrossRef
19.
go back to reference Pascom ARP, Habckost CB, Lobo TDM, Pasini EN, Comparini RA, Mesquita FC. Expanding HIV testing among key populations in Brazil: a peer pointofcare testing project experience. Bull World Health Organ. 2016;94(8):263-270. Pascom ARP, Habckost CB, Lobo TDM, Pasini EN, Comparini RA, Mesquita FC. Expanding HIV testing among key populations in Brazil: a peer pointofcare testing project experience. Bull World Health Organ. 2016;94(8):263-270.
20.
go back to reference de Barros CHD, Sabidó M, de Miranda Lobo TD, Pascom RP, Pasini E, Mesquita F, Benzaken A. Community-based rapid HIV testing in Brazil for vulnerable populations: whom are we reaching? J AIDS Clin Res. 2017;8:1000679. de Barros CHD, Sabidó M, de Miranda Lobo TD, Pascom RP, Pasini E, Mesquita F, Benzaken A. Community-based rapid HIV testing in Brazil for vulnerable populations: whom are we reaching? J AIDS Clin Res. 2017;8:1000679.
21.
go back to reference Ndawinz JD, Costagliola D, Supervie V. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France. AIDS. 2011;25(15):1905–13.CrossRef Ndawinz JD, Costagliola D, Supervie V. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France. AIDS. 2011;25(15):1905–13.CrossRef
Metadata
Title
Decline in reported AIDS cases in Brazil after implementation of the test and treat initiative
Authors
Gerson Fernando Mendes Pereira
Meritxell Sabidó
Alessandro Caruso
Adele Schwartz Benzaken
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4018-z

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.